Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1098, pseudogene (RNU6-1098P) is a human pseudogene derived from the U6 small nuclear RNA family, located on chromosome 3, and is not considered a therapeutic, functional, or protein-coding target[1][3][5][7]. There is no experimental or clinical evidence supporting any defined biological activity or disease association for this pseudogene. RNA, U6 small nuclear 1098, pseudogene (RNU6-1098P) is a human pseudogene annotated based on sequence similarity to U6 small nuclear RNA (snRNA), part of the spliceosome machinery in functional contexts. Unlike the active U6 snRNA genes, RNU6-1098P lacks coding or regulatory function and does not produce a functional transcript[1][3][5][7]. It is mapped to chromosome 3, and its annotation arises from genomic surveys identifying snRNA pseudogenes, which are common throughout the human genome but generally do not encode proteins, regulate genes, nor serve as druggable or diagnostic targets[1][3][5][7][8]. There is currently no evidence for molecular, cellular, or clinical roles, making it an informational annotation without therapeutic, diagnostic, or biological significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1098, pseudogene (RNU6-1098P).